Literature DB >> 22949369

Severity scoring systems: are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?

Gabrielle B McCallum1, Peter S Morris, Clare C Wilson, Lesley A Versteegh, Linda M Ward, Mark D Chatfield, Anne B Chang.   

Abstract

BACKGROUND: Severity scores are commonly used in research and clinically to assess the severity of bronchiolitis. However, there are limitations as few have been validated. The aim of our study was to: (i) determine the validity and reliability of a bronchiolitis scoring system, and (ii) examine if the score predicted the need for oxygen at 12 and 24 hrs. Children aged <24 months presenting to Royal Darwin Hospital with a clinical diagnosis of bronchiolitis were eligible to participate. STUDY
DESIGN: We reviewed published papers that used a bronchiolitis score and summarized the data in a table. We chose the Tal score that was easy to use and encompassed clinically important parameters. Three research nurses, trained to assess children, used two scoring systems (Tal and Modified-Tal; respiratory rate, accessory muscle use, wheezing, cyanosis, and oxygen saturation), blindly evaluated children within 15 min of each other.
RESULTS: The children's (n = 115) median age was 5.4 months (IQR 2.9, 10.4); 65% were male and 64% were Indigenous. Internal consistency was excellent (Tal: Cronbach α = 0.66; Modified-Tal: α = 0.70). There was substantial inter-rater agreement; weighted kappa of 0.72 (95% CI: 0.63, 0.83) for Tal and 0.70 (95% CI: 0.63, 0.76) for Modified-Tal. For predicting requirement for oxygen at 12 and 24 hrs; area under receiver operating curve (aROC) was 0.69 (95% CI: 0.13, 1.0) and 0.75 (95% CI: 0.34, 1.0), respectively.
CONCLUSION: The Tal and Modified-Tal scoring systems for bronchiolitis is repeatable and can reliably be used in research and clinical practice. Its utility for prediction of O2 requirement is limited.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  RDAI; bronchiolitis severity scoring; respiratory distress assessment instrument

Mesh:

Substances:

Year:  2012        PMID: 22949369     DOI: 10.1002/ppul.22627

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  24 in total

1.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

2.  Validation of a scale to assess the severity of bronchiolitis in a population of hospitalized infants.

Authors:  Diana M Duarte-Dorado; Danitza S Madero-Orostegui; Carlos E Rodriguez-Martinez; Gustavo Nino
Journal:  J Asthma       Date:  2013-09-19       Impact factor: 2.515

3.  Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.

Authors:  Mary T Caserta; Xing Qiu; Brenda Tesini; Lu Wang; Amy Murphy; Anthony Corbett; David J Topham; Ann R Falsey; Jeanne Holden-Wiltse; Edward E Walsh
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

Review 4.  Systematic review of instruments aimed at evaluating the severity of bronchiolitis.

Authors:  Carlos E Rodriguez-Martinez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  Paediatr Respir Rev       Date:  2017-02-15       Impact factor: 2.726

5.  Upper respiratory tract bacterial-immune interactions during respiratory syncytial virus infection in infancy.

Authors:  Christian Rosas-Salazar; Zheng-Zheng Tang; Meghan H Shilts; Kedir N Turi; Qilin Hong; Derek A Wiggins; Christian E Lynch; Tebeb Gebretsadik; James D Chappell; R Stokes Peebles; Larry J Anderson; Suman R Das; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2021-09-14       Impact factor: 14.290

Review 6.  Bronchodilators for bronchiolitis.

Authors:  Anne M Gadomski; Melissa B Scribani
Journal:  Cochrane Database Syst Rev       Date:  2014-06-17

7.  Respiratory Severity Score Separates Upper Versus Lower Respiratory Tract Infections and Predicts Measures of Disease Severity.

Authors:  Amy S Feldman; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll; Patricia A Minton; Kimberly B Woodward; Emma K Larkin; Eva Kathryn Miller; Robert S Valet
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-06-01       Impact factor: 1.349

8.  Increased healthcare resource utilization for acute respiratory illness among Latino infants.

Authors:  Robert S Valet; Tebeb Gebretsadik; Kecia N Carroll; Patricia A Minton; Kimberly B Woodward; Zhouwen Liu; Rachel Hayes; Tina V Hartert
Journal:  J Pediatr       Date:  2013-05-24       Impact factor: 4.406

9.  Gastroesophageal Reflux Disease Increases Infant Acute Respiratory Illness Severity, but not Childhood Asthma.

Authors:  Robert S Valet; Kecia N Carroll; Tebeb Gebretsadik; Patricia A Minton; Kimberly B Woodward; Zhouwen Liu; Tina V Hartert
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

10.  Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States.

Authors:  Gloria S Pryhuber; Nathalie L Maitre; Roberta A Ballard; Denise Cifelli; Stephanie D Davis; Jonas H Ellenberg; James M Greenberg; James Kemp; Thomas J Mariani; Howard Panitch; Clement Ren; Pamela Shaw; Lynn M Taussig; Aaron Hamvas
Journal:  BMC Pediatr       Date:  2015-04-10       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.